Literature DB >> 21218505

Islet amyloid polypeptide acts on glucose- stimulated beta cells to reduce voltage-gated calcium channel activation, intracellular Ca(2+) concentration, and insulin secretion.

Tiehong Zhu1, Yinxia Wang, Bingjun He, Jingjing Zang, Qing He, Weihua Zhang.   

Abstract

OBJECTIVE: the mechanism by which islet amyloid polypeptide (IAPP) inhibits insulin release is unclear. We hypothesized that reduced voltage-gated calcium channel activity and intracellular Ca(2+) concentration might contribute to IAPP-mediated inhibition of glucose-stimulated insulin release. RESEARCH DESIGN AND METHODS: rat islet beta cells were cultured and treated with various extracellular concentrations of IAPP, and insulin release was stimulated via addition of glucose. Activation voltage, high voltage-gated calcium channel currents, intracellular Ca(2+) concentration, and insulin secretion were detected by patch clamp electrophysiology, fluorescent digital imaging microscopy using calcium-sensitive fluorescent dye, and radioimmunoassay, respectively.
RESULTS: high voltage-gated calcium channel currents, intracellular Ca(2+) concentration, and insulin secretion increased in a dose-dependent manner when rat beta cells were exposed to glucose. After short-term IAPP treatment (5 or 10 µM), these parameters decreased significantly in glucose-stimulated beta cells. However, no significant changes were observed with lower doses of IAPP.
CONCLUSIONS: glucose-stimulated islet beta-cell high voltage-gated calcium channels were activated in conjunction with insulin secretion, while high extracellular concentrations of IAPP inhibited beta-cell high voltage-gated calcium channel activation and insulin secretion in a dose-dependent manner. 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21218505     DOI: 10.1002/dmrr.1140

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

1.  Involvement of ATP-sensitive potassium (K(ATP)) channels in the loss of beta-cell function induced by human islet amyloid polypeptide.

Authors:  Maud Soty; Montse Visa; Sergi Soriano; María del Carmen Carmona; Ángel Nadal; Anna Novials
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

Review 2.  Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.

Authors:  Lance Thielen; Anath Shalev
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-04       Impact factor: 3.243

3.  Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through miR-124a and FoxA2.

Authors:  Gu Jing; Clara Westwell-Roper; Junqin Chen; Guanlan Xu; C Bruce Verchere; Anath Shalev
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

4.  Drosophila melanogaster as a model system for studies of islet amyloid polypeptide aggregation.

Authors:  Sebastian Wolfgang Schultz; K Peter R Nilsson; Gunilla Torstensdotter Westermark
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

Review 5.  Amylin uncovered: a review on the polypeptide responsible for type II diabetes.

Authors:  Karen Pillay; Patrick Govender
Journal:  Biomed Res Int       Date:  2013-03-31       Impact factor: 3.411

Review 6.  On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides.

Authors:  Marianna Flora Tomasello; Alessandro Sinopoli; Giuseppe Pappalardo
Journal:  J Diabetes Res       Date:  2015-10-25       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.